Description
The PAPP-A Test is a essential prenatal blood test performed in the first trimester (usually between weeks 11 and 14). It measures a protein produced by the placenta and is primarily used as a key biomarker in combined screening to assess the risk of the baby having certain chromosomal abnormalities, such as Down syndrome.
Pregnancy-Associated Plasma Protein-A (PAPP-A) is a large glycoprotein produced by the developing placenta. Its concentration in maternal blood typically rises rapidly as the first trimester progresses. The PAPP-A test is rarely performed alone; it is almost always part of a combined first-trimester screening, which statistically estimates the risk of fetal chromosomal disorders.
Clinical Significance: This test is a critical component of prenatal care for several reasons:
-
Chromosomal Abnormality Screening: Lower-than-average levels of PAPP-A during the first trimester are strongly associated with an increased risk of specific fetal conditions, most notably Down syndrome (Trisomy 21) and Edwards syndrome (Trisomy 18).
-
Guiding Further Diagnostic Steps: If the combined screening (PAPP-A, hCG blood markers, and Nuchal Translucency ultrasound) indicates a high risk, healthcare providers can offer definitive diagnostic tests like Chorionic Villus Sampling (CVS) or Non-Invasive Prenatal Testing (NIPT) early in the pregnancy.
-
Placental Function: More recently, very low PAPP-A levels have been linked to potential, though not certain, risks of other pregnancy complications later on, such as intrauterine growth restriction (IUGR) or preeclampsia, serving as an early indicator for closer maternal monitoring.
When is this test recommended?
-
Strict Timing: The test is most accurate when performed between 10 weeks, 0 days and 13 weeks, 6 days of gestation.
-
Combined Screening: It is recommended for all pregnant women as part of the initial “First Trimester Combined Screening.”
Sample Requirements:
-
Specimen: Serum (Maternal Blood).
-
Container: Gold Top (SST) or Red Top Tube.
-
Preparation: No fasting is required.
-
Crucial Handling: The test requires precise calculation based on the gestational age. Clinical information, including maternal age, weight, and correct dating of the pregnancy (often confirmed by ultrasound), is essential to interpret the result as a “Multiple of the Median (MoM).”
